With over 374 million new STI cases reported annually and a sharp rise in antibiotic-resistant gonorrhoea and congenital syphilis, the global need for reliable diagnostic tools has never been greater.
🔬 At AbBaltis, we’re proud to support this critical need by supplying high-quality PCR controls and diagnostic markers for key STIs, including:
✔️ Chlamydia trachomatis
✔️ Neisseria gonorrhoeae
✔️ Trichomonas vaginalis
✔️ Mycoplasma genitalium
✔️ Treponema pallidum (Syphilis)
💡 Our products help ensure:
✅ High assay sensitivity and specificity
✅ Consistency in molecular testing
✅ Reliable results that support targeted treatment and reduce antibiotic misuse
By providing dependable reagents and controls, AbBaltis enables laboratories and diagnostic manufacturers worldwide to detect infections early and respond to the growing public health challenge with confidence.
Let’s work together to drive better outcomes in global sexual health.
Source: https://lnkd.in/eXAHy2mi